Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers

We are analyzing https://www.nature.com/articles/s41523-024-00665-z.

Title:
EMBER creates a unified space for independent breast cancer transcriptomic datasets enabling precision oncology | npj Breast Cancer
Description:
Transcriptomics has revolutionized biomedical research and refined breast cancer subtyping and diagnostics. However, wider use in clinical practice is hampered for a number of reasons including the application of transcriptomic signatures as single sample predictors. Here, we present an embedding approach called EMBER that creates a unified space of 11,000 breast cancer transcriptomes and predicts phenotypes of transcriptomic profiles on a single sample basis. EMBER accurately captures the five molecular subtypes. Key biological pathways, such as estrogen receptor signaling, cell proliferation, DNA repair, and epithelial-mesenchymal transition determine sample position in the space. We validate EMBER in four independent patient cohorts and show with samples from the window trial, POETIC, that it captures clinical responses to endocrine therapy and identifies increased androgen receptor signaling and decreased TGFβ signaling as potential mechanisms underlying intrinsic therapy resistance. Of direct clinical importance, we show that the EMBER-based estrogen receptor (ER) signaling score is superior to the immunohistochemistry (IHC) based ER index used in current clinical practice to select patients for endocrine therapy. As such, EMBER provides a calibration and reference tool that paves the way for using RNA-seq as a standard diagnostic and predictive tool for ER+ breast cancer.
Website Age:
30 years and 1 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (9)
google.com, onomagic.com, onlinemediasolutions.com, sparcmedia.com, brightcom.com, audienciad.com, aps.amazon.com, yourbow.com, x.adprime.com

Reseller Advertisers (40)
rubiconproject.com, pubmatic.com, appnexus.com, video.unrulymedia.com, sharethrough.com, google.com, smartadserver.com, onetag.com, openx.com, yahoo.com, triplelift.com, media.net, smaato.com, conversantmedia.com, inmobi.com, themediagrid.com, indexexchange.com, 33across.com, adingo.jp, contextweb.com, axonix.com, outbrain.com, instreamatic.com, omnifytv.com, 152media.info, consumable.com, atasdigital.com, krushmedia.com, rhythmone.com, amxrtb.com, yieldmo.com, adyoulike.com, adform.com, adpone.com, criteo.com, lijit.com, richaudience.com, sovrn.com, improvedigital.com, smilewanted.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

Display Ads ~ $48,000 per month
Our calculations suggest that Nature.com earns between $32,032 and $88,088 monthly online from display advertisements.

Keywords {🔍}

samples, cancer, breast, molecular, article, metabric, fig, ember, scores, scanb, pubmed, data, signaling, genes, google, scholar, tcga, index, score, analysis, ihc, patients, average, estrogen, clinical, cohorts, embedding, sample, expression, response, cas, gene, supplementary, patient, therapy, endocrine, cohort, figure, early, nature, subtypes, receptor, information, central, space, poetic, pcpc, signatures, rnaseq, tumor,

Topics {✒️}

loading [mathjax]/jax/output/html-css/config nature portfolio code availability author information authors pi3k/akt/mtor signaling drive data availability editing molecular markers adjacent sections regional office nature 406 nature 486 nature 490 nature 462 nature leveraging patient-partnered research encompass single-sample-based approaches34 powerful tools $${\rm{cv}}=\frac{{\rm{standard pi3k/akt/mtor signaling pgc-1α-responsive genes involved figures initiative sharing original author experimental cancer research author correspondence reprints provided additional information additional biological information early-stage breast cancer io/transcriptomics epithelial-mesenchymal transition open manner35 revolutionized biomedical research cancer research npj breast cancer accession code gse105777 io/molecular_landscape including stephen-john sammut asco/cap guideline update discussion genomics data rna sequencing-based datasets similar content breast cancer index early breast cancer additional biological features large-scale multicenter infrastructure ember-based estrogen receptor

Schema {🗺️}

WebPage:
      mainEntity:
         headline:EMBER creates a unified space for independent breast cancer transcriptomic datasets enabling precision oncology
         description:Transcriptomics has revolutionized biomedical research and refined breast cancer subtyping and diagnostics. However, wider use in clinical practice is hampered for a number of reasons including the application of transcriptomic signatures as single sample predictors. Here, we present an embedding approach called EMBER that creates a unified space of 11,000 breast cancer transcriptomes and predicts phenotypes of transcriptomic profiles on a single sample basis. EMBER accurately captures the five molecular subtypes. Key biological pathways, such as estrogen receptor signaling, cell proliferation, DNA repair, and epithelial-mesenchymal transition determine sample position in the space. We validate EMBER in four independent patient cohorts and show with samples from the window trial, POETIC, that it captures clinical responses to endocrine therapy and identifies increased androgen receptor signaling and decreased TGFβ signaling as potential mechanisms underlying intrinsic therapy resistance. Of direct clinical importance, we show that the EMBER-based estrogen receptor (ER) signaling score is superior to the immunohistochemistry (IHC) based ER index used in current clinical practice to select patients for endocrine therapy. As such, EMBER provides a calibration and reference tool that paves the way for using RNA-seq as a standard diagnostic and predictive tool for ER+ breast cancer.
         datePublished:2024-07-09T00:00:00Z
         dateModified:2024-07-09T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41523-024-00665-z
         keywords:
            Breast cancer
            Cancer genomics
            Predictive markers
            Biomedicine
            general
            Cancer Research
            Oncology
            Human Genetics
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig6_HTML.png
         isPartOf:
            name:npj Breast Cancer
            issn:
               2374-4677
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Carlos Ronchi
               url:http://orcid.org/0000-0002-8079-8643
               affiliation:
                     name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
                     address:
                        name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Syed Haider
               url:http://orcid.org/0000-0001-6685-5480
               affiliation:
                     name:The Institute of Cancer Research
                     address:
                        name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cathrin Brisken
               url:http://orcid.org/0000-0002-6857-3230
               affiliation:
                     name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
                     address:
                        name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
                        type:PostalAddress
                     type:Organization
                     name:The Institute of Cancer Research
                     address:
                        name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:EMBER creates a unified space for independent breast cancer transcriptomic datasets enabling precision oncology
      description:Transcriptomics has revolutionized biomedical research and refined breast cancer subtyping and diagnostics. However, wider use in clinical practice is hampered for a number of reasons including the application of transcriptomic signatures as single sample predictors. Here, we present an embedding approach called EMBER that creates a unified space of 11,000 breast cancer transcriptomes and predicts phenotypes of transcriptomic profiles on a single sample basis. EMBER accurately captures the five molecular subtypes. Key biological pathways, such as estrogen receptor signaling, cell proliferation, DNA repair, and epithelial-mesenchymal transition determine sample position in the space. We validate EMBER in four independent patient cohorts and show with samples from the window trial, POETIC, that it captures clinical responses to endocrine therapy and identifies increased androgen receptor signaling and decreased TGFβ signaling as potential mechanisms underlying intrinsic therapy resistance. Of direct clinical importance, we show that the EMBER-based estrogen receptor (ER) signaling score is superior to the immunohistochemistry (IHC) based ER index used in current clinical practice to select patients for endocrine therapy. As such, EMBER provides a calibration and reference tool that paves the way for using RNA-seq as a standard diagnostic and predictive tool for ER+ breast cancer.
      datePublished:2024-07-09T00:00:00Z
      dateModified:2024-07-09T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41523-024-00665-z
      keywords:
         Breast cancer
         Cancer genomics
         Predictive markers
         Biomedicine
         general
         Cancer Research
         Oncology
         Human Genetics
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig6_HTML.png
      isPartOf:
         name:npj Breast Cancer
         issn:
            2374-4677
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Carlos Ronchi
            url:http://orcid.org/0000-0002-8079-8643
            affiliation:
                  name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
                  address:
                     name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Syed Haider
            url:http://orcid.org/0000-0001-6685-5480
            affiliation:
                  name:The Institute of Cancer Research
                  address:
                     name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cathrin Brisken
            url:http://orcid.org/0000-0002-6857-3230
            affiliation:
                  name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
                  address:
                     name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
                     type:PostalAddress
                  type:Organization
                  name:The Institute of Cancer Research
                  address:
                     name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:npj Breast Cancer
      issn:
         2374-4677
      volumeNumber:10
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
      address:
         name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
         type:PostalAddress
      name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
      address:
         name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
         type:PostalAddress
      name:The Institute of Cancer Research
      address:
         name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Carlos Ronchi
      url:http://orcid.org/0000-0002-8079-8643
      affiliation:
            name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
            address:
               name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
               type:PostalAddress
            type:Organization
      name:Syed Haider
      url:http://orcid.org/0000-0001-6685-5480
      affiliation:
            name:The Institute of Cancer Research
            address:
               name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      name:Cathrin Brisken
      url:http://orcid.org/0000-0002-6857-3230
      affiliation:
            name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
            address:
               name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
               type:PostalAddress
            type:Organization
            name:The Institute of Cancer Research
            address:
               name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
      name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
      name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
      name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK

External Links {🔗}(165)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Ember.js
  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk
6.23s.